Clinical trials: Placenta Praevia
Placenta Previa
17-Alpha-Hydroxyprogesterone Caproate in Pregnant Women With Placenta Previa
Purpose to evaluate the effects of intramuscular 17-Alpha-Hydroxyprogesterone Caproate (17-OHPC) for prevention of Emergent Cesarean Delivery in symptomatic Pregnant Women with Placenta Previa
- Trial name
- NCT03779438
- Testing
- 17-OHPC
- Where
- Egypt
- Volunteers
- 300 people
- Sponsor
- Aswan University Hospital
Placenta Previa, Post Partum Hemorrhage
Glove-loaded Foley's Catheter Tamponade for Cesarean Section for Placenta Previa
Objective: To investigate the effect of A glove-loaded Foley's catheter tamponade versus stepwise uterine devascularization on blood loss during cesarean section (CS) in patients with complete placenta previa.
- Trial name
- NCT03570723
- Testing
- A glove-loaded Foley's catheter tamponade, stepwise uterine devascularization
- Where
- Egypt
- Volunteers
- 120 people
- Sponsor
- Aswan University Hospital
Placenta Previa, Placenta Accreta
Management of Placenta Accreta Spectrum
placenta accreta spectrum is group of disorders which have a depate about the best way of management. this is a descriptive study about the best techniques to reduce morbidity and mortalities related to it.
- Trial name
- NCT04609527
- Testing
- Management of placenta accreta spectrum
- Where
- 2 sites in Egypt
- Volunteers
- 30 people
- Sponsor
- Assiut University
Complications; Cesarean Section
Spinal Aesthesia in Women With Placenta Previa Percreta
Placenta previa percreta is a dangerous complication during surgery. Due to the high risk of hemorrhage, most parturients with placenta previa have to accept cesarean section.
- Trial name
- SAW (NCT02686242)
- Testing
- spinal anesthesia, general anesthesia
- Where
- China
- Volunteers
- 68 people
- Sponsor
- Air Force Military Medical University, China
Morbidly Adherent Placenta, Placenta Accreta
Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta
The purpose of this study is to determine whether, in a high risk population (placenta praevia and previous caesarean or prenatal suspicion of morbidly adherent placenta (MAP)), the concentration of cell-free fetal DNA…
- Conditions
- Morbidly Adherent Placenta, Placenta Accreta, Placenta Increta, Placenta Percreta
- Trial name
- DNA-Accreta (NCT02784886)
- Testing
- Women at high risk of MAP
- Where
- France
- Volunteers
- 63 people
- Sponsor
- University Hospital, Angers
Placenta Previa
Tranexamic Acid vs Vasopressin in Placenta Previa Trial
Placenta previa is a major obstetric condition associated with increased risk of excessive blood loss during cesarean section, leading to maternal morbidity and mortality.
- Trial name
- TXA-VASO-PP (NCT07423156)
- Testing
- Group A: Tranexamic acid, Group B: Vasopressin
- Where
- Pakistan
- Volunteers
- 58 people
- Sponsor
- Allama Iqbal Medical College
Placenta Accreta
Hysteroscopic Follow-up Following Conservative Stepwise Surgical Approach for Management of Placenta Previa Accreta
Conservative management of placenta accreta spectrum can preserve future fertility but should only be done in hospitals with enough experience as it carries a high risk of maternal complications.
- Trial name
- NCT06029985
- Testing
- Hysteroscopic Follow Up
- Where
- Egypt
- Volunteers
- 50 people
- Sponsor
- Ain Shams Maternity Hospital
Pregnancy, Eclampsia
A Cluster-Randomized Trial of Ultrasound Use to Improve Pregnancy Outcomes in Low Income Country Settings
In many low-income countries, the use of ultrasound by medical officers and non-physician health care staff (e.g., midwives) for antenatal identification of high risk pregnancies is a new intervention requiring authoritative…
- Conditions
- Pregnancy, Eclampsia, Placenta Previa, Stillbirth
- Trial name
- NCT01990625
- Testing
- Antenatal Ultrasound Scan
- Where
- 5 sites in Guatemala, Kenya and 3 more
- Volunteers
- 45,038 people, healthy volunteers welcome
- Sponsor
- NICHD Global Network for Women's and Children's Health
Placenta Previa
Tocolytic Therapy in Conservative Management of Symptomatic Placenta Previa
The objective of our study is to determine the clinical utility related to the maintenance oral nifedipine therapy in patients with symptomatic placenta previa.
- Trial name
- NCT00620724
- Testing
- Nifedipine
- Where
- France
- Volunteers
- 109 people
- Sponsor
- University Hospital, Rouen
Bleeding, Placenta Previa
Bakri Balloon in Placenta Previa
The Bakri intrauterine balloon can achieve haemostasis in cases of postpartum haemorrhage, including haemorrhage associated with placenta previa by compressing the lower uterine segment.
- Trial name
- BB-ATS (NCT02694341)
- Testing
- Abdominal traction stitch, Bakri Balloon
- Where
- Egypt
- Sponsor
- Assiut University
Cesarean Section; Complications, Placenta Previa
Long Term Comparison of Two Different Techniques of Uterine Cesarean Incision Closure
Cesarean section (C/S) is an operation most commonly performed in Obstetrics and Gynecology Clinics. Complications related with incomplete healing of Kerr uterine incision after C/S (adhesions, separation (dehiscence)…
- Conditions
- Cesarean Section; Complications, Placenta Previa, Placenta Accreta
- Trial name
- NCT01289262
- Testing
- Purse string closure technique, Continuously locked closure technique
- Where
- Turkey (Türkiye)
- Volunteers
- 168 people
- Sponsor
- Dr. Lutfi Kirdar Kartal Training and Research Hospital
Interventional Drug in Placenta Previa
Tranexamic Acid as an Intervention in Placenta Previa
Antepartum hemorrhage (APH) due to placenta previa is an important cause of worldwide perinatal mortality and maternal morbidity in pregnant women
- Trial name
- NCT05688111
- Testing
- Tranexamic acid injection, Glucose water 5%
- Where
- 2 sites in Iraq
- Volunteers
- 146 people
- Sponsor
- Hawler Medical University
Morbidly Adherent Placenta
Role of Ultrasound in Diagnosis of Placenta Previa and MAP
Placenta accreta occurs when the placental implantation is abnormal. The marked rise in incidence has been assumed the increasing prevalence of cesarean delivery in recent years.
- Trial name
- NCT03416296
- Where
- Egypt
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- Aljazeera Hospital
Placenta Previa
Vaginal Pessary Versus Expectant Management for Placenta Previa
The purpose of this study is to perform a large multi-center randomized trial comparing the role of vaginal pessary versus expectant management in women with placenta previa between 22w0d and 32w0d of gestation in prolonging…
- Trial name
- NCT01996345
- Testing
- Cervical Pessary Placement
- Where
- 10 sites in United States
- Volunteers
- 17 people
- Sponsor
- Pediatrix
Cervical IO Plasty in Management of Placenta Previa
Cervical Internal os Plasty in Management of Placenta Previa and Focal Accreta
Aim of the work: Better management \& reducing hemorrhage and complication in patients placenta previa and focal accreta .
- Trial name
- NCT05560984
- Testing
- cervical internal os plasty
- Volunteers
- 40 people
- Sponsor
- Zagazig University
Postpartum Hemorrhage
TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA
Several randomized, controlled trials, mostly involving women undergoing cesarean delivery, have shown that the prophylactic intravenous administration of 1 g of tranexamic acid after childbirth reduced blood loss.
- Trial name
- TRAAPrevia (NCT04304625)
- Testing
- Tranexamic Acid / Sodium chloride
- Where
- France
- Volunteers
- 1,380 people
- Sponsor
- University Hospital, Bordeaux
Threatened Premature Birth, Premature Membrane Rupture
Intervention for Fear of Childbirth in High-Risk Pregnant Women
The aim of the study is to examine the effects of mandala activity applied to pregnant women hospitalized due to high-risk pregnancies on pregnancy stress and fear of childbirth. The study was designed as an experimental study.
- Conditions
- Threatened Premature Birth, Premature Membrane Rupture, Gestational Hypertension, Intrauterine Growth Retardation (IUGR)
- Trial name
- NCT06716710
- Testing
- Art therapy group, Control group
- Where
- Turkey (Türkiye)
- Volunteers
- 149 people, healthy volunteers welcome
- Sponsor
- Kocaeli University
Placenta Accreta
Conservative Surgery for Placenta Accreta
A stepwise surgical approach for conservative management of placenta previa accreta.
- Trial name
- NCT04981483
- Testing
- conservative surgery for uterus in placenta accreta
- Where
- Egypt
- Volunteers
- 62 people, healthy volunteers welcome
- Sponsor
- Ain Shams University
Placenta Previa, Placenta Accreta
Outcomes of Placenta Accreta Spectrum Disorders Surgery in Relation to Placenta Accreta Scoring Index
Using of Ultra sound in assessment of Placenta Accreta Index to predict the surgical outcomes of Placenta accreta
- Trial name
- NCT06220760
- Testing
- Ultrasound
- Where
- Egypt
- Volunteers
- 154 people, healthy volunteers welcome
- Sponsor
- Assiut University
Placenta Previa, Placenta Accreta Spectrum
Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta
Current clinical practice guidelines recommend planned cesarean delivery(CD) at 34-37 weeks of gestation in pregnant women with placenta previa and accreta.
- Conditions
- Placenta Previa, Placenta Accreta Spectrum, Antepartum Bleeding, Emergency Cesarean Section
- Trial name
- NCT07025954
- Testing
- Cesarean delivery
- Where
- 6 sites in China
- Volunteers
- 600 people
- Sponsor
- The Third Affiliated Hospital of Guangzhou Medical University